MDT

96.91

-0.67%↓

A

147.87

-0.47%↓

VEEV

232.45

-3%↓

HQY

84.34

-10.55%↓

PHR.US

17.13

-0.23%↓

MDT

96.91

-0.67%↓

A

147.87

-0.47%↓

VEEV

232.45

-3%↓

HQY

84.34

-10.55%↓

PHR.US

17.13

-0.23%↓

MDT

96.91

-0.67%↓

A

147.87

-0.47%↓

VEEV

232.45

-3%↓

HQY

84.34

-10.55%↓

PHR.US

17.13

-0.23%↓

MDT

96.91

-0.67%↓

A

147.87

-0.47%↓

VEEV

232.45

-3%↓

HQY

84.34

-10.55%↓

PHR.US

17.13

-0.23%↓

MDT

96.91

-0.67%↓

A

147.87

-0.47%↓

VEEV

232.45

-3%↓

HQY

84.34

-10.55%↓

PHR.US

17.13

-0.23%↓

Search

Stevanato Group SpA

Fermé

SecteurSoins de santé

20.54 -2.38

Résumé

Variation du prix de l'action

24h

Actuel

Min

20.54

Max

20.91

Chiffres clés

By Trading Economics

Revenu

10M

49M

Ventes

23M

303M

P/E

Moyenne du Secteur

35.083

87.826

BPA

0.162

Rendement du dividende

0.26

Marge bénéficiaire

16.205

Employés

5,521

EBITDA

10M

73M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+23.18% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.26%

2.26%

Prochains Résultats

5 mars 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-991M

5.7B

Ouverture précédente

22.92

Clôture précédente

20.54

Sentiment de l'Actualité

By Acuity

50%

50%

173 / 370 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bullish Evidence

Stevanato Group SpA Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

12 janv. 2026, 23:54 UTC

Market Talk

CBA Could Underperform Again in 2026 -- Market Talk

12 janv. 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 janv. 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

12 janv. 2026, 23:43 UTC

Market Talk

Gold Edges Lower on Likely Technical Correction -- Market Talk

12 janv. 2026, 23:18 UTC

Acquisitions, Fusions, Rachats

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

12 janv. 2026, 21:56 UTC

Market Talk

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

12 janv. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 janv. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

12 janv. 2026, 21:50 UTC

Market Talk
Résultats

Auto & Transport Roundup: Market Talk

12 janv. 2026, 21:18 UTC

Market Talk

Global Equities Roundup: Market Talk

12 janv. 2026, 21:18 UTC

Market Talk

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

12 janv. 2026, 20:54 UTC

Résultats

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

12 janv. 2026, 20:48 UTC

Market Talk

Oil Futures Settle Higher in Choppy Trade -- Market Talk

12 janv. 2026, 20:33 UTC

Market Talk

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

12 janv. 2026, 20:18 UTC

Acquisitions, Fusions, Rachats

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

12 janv. 2026, 20:18 UTC

Acquisitions, Fusions, Rachats

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

12 janv. 2026, 19:39 UTC

Market Talk

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

12 janv. 2026, 19:36 UTC

Market Talk

Gold and Silver Set New Records on Fed Probe -- Market Talk

12 janv. 2026, 19:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 janv. 2026, 19:33 UTC

Market Talk

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

12 janv. 2026, 19:24 UTC

Acquisitions, Fusions, Rachats

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

12 janv. 2026, 19:22 UTC

Acquisitions, Fusions, Rachats

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

12 janv. 2026, 18:21 UTC

Acquisitions, Fusions, Rachats

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

12 janv. 2026, 18:20 UTC

Acquisitions, Fusions, Rachats

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

12 janv. 2026, 18:19 UTC

Market Talk

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

12 janv. 2026, 18:16 UTC

Market Talk
Acquisitions, Fusions, Rachats

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

12 janv. 2026, 18:09 UTC

Market Talk

Global Equities Roundup: Market Talk

12 janv. 2026, 18:09 UTC

Market Talk

Baidu's Outlook Bodes Well For Shares -- Market Talk

12 janv. 2026, 18:01 UTC

Acquisitions, Fusions, Rachats

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

12 janv. 2026, 18:00 UTC

Market Talk

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Comparaison

Variation de prix

Stevanato Group SpA prévision

Objectif de Prix

By TipRanks

23.18% hausse

Prévisions sur 12 Mois

Moyen 27 USD  23.18%

Haut 30 USD

Bas 24 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

3 ratings

2

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

21.56 / 22.61Support & Résistance

Court Terme

Weak Bullish Evidence

Moyen Terme

Weak Bearish Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

173 / 370Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat